Who owns Celldex Therapeutics?
- Ticker: CLDX
- CUSIP Number: 15117B103
Top Holders and Investors of CLDX Stock
Find out what company owns Celldex Therapeutics, who bought CLDX this quarter, and who sold shares of CLDX stock?
| Fund or Company Name | Number of Shares | Valued At | As Of |
|---|---|---|---|
| Meditor | 420846 | $896401 | Sep 2019 |
| Benchmark Capital Advisors | 32600 | $5868 | Dec 2018 |
| Horizon Kinetics | 26335 | $0 | Dec 2018 |
Who sold Celldex Therapeutics?
| Fund Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| KLP Enterprises | Dec. 31, 2018 | 6.87M | $1.37M |
| UBS Group AG | Dec. 31, 2018 | 68194 | $21822 |
Funds that own CLDX also own:
- ANSYS (ANSS)
- Corning Incorporated (GLW)
- Broadridge Financial Solutions (BR)
- Signature Bank (SBNY)
- Affiliated Managers (AMG)
- Expeditors International of Washington (EXPD)
- Abbott Laboratories (ABT)
- Baxter International (BAX)
- Johnson & Johnson (JNJ)
- Pfizer (PFE)
- Cardinal Health (CAH)
- Bristol Myers Squibb (BMY)
- IDEXX Laboratories (IDXX)
- J.B. Hunt Transport Services (JBHT)
- Polaris Industries (PII)
- BE Aerospace (BEAV)
- Newell Rubbermaid (NWL)
- SVB Financial (SIVB)
- Hanesbrands (HBI)
- VCA Antech (WOOF)
- Celldex Therapeutics (CLDX)